On May 24, shares in the First Capital Inc. company were selling at $25.18.
First Capital Inc. employs 184 people and has reported $13,190,000 in income as of May 24.
In the fluctuating stock market, healthcare and technology stocks are viewed as the safest bets for long-term gains.
Besty Kuekcer with Benzinga.com said healthcare-related stocks, such as hospital conglomerates and insurance companies, have weathered numerous economic crises and still make a profit, meaning they’re a stable investment.
While technology stocks can be more risky, given the boom-bust nature of new tech companies, Kuecker recommended a diverse portfolio of tech companies to strike it big when companies succeed or sell to other larger companies.
For short-term investments, Kuecker recommended “consumer discretionary” stocks, which are sensitive to economic changes but can rise greatly on the back of a strong economy.
Nothing in this article is to be assumed as financial advice.
Individual companies can have several different types of shares across many stock markets. It is possible for different types of shares to see different results on the market.
Company Name | % of Change in Last Year | Selling Price |
---|---|---|
Digital Brand Media & Marketing Group Inc. | 1,900% | $0.01 |
Bravo Multinational Inc. | 1,847.23% | $0.6901 |
America Great Health | 1,400% | $0.003 |
Ameritek Ventures Inc | 753.33% | $0.0128 |
Cabaletta Bio Inc. | 702.34% | $10.27 |
Bellerophon Therapeutics Inc. | 675.37% | $7.48 |
Ardelyx Inc. | 489.92% | $3.51 |
89Bio Inc. | 488.85% | $16.37 |
Biomea Fusion Inc. | 482.56% | $32.74 |
Blue Dolphin Energy Co. | 441.27% | $3.41 |
Akero Therapeutics Inc. | 435.6% | $44.08 |
Atlas Lithium Corp | 420.25% | $20.68 |
Eline Entertainment Group Inc | 400% | $0.0005 |
Burzynski Research Institute Inc. | 388.33% | $0.0733 |
Arcellx Inc | 376.72% | $43 |
Akebia Therapeutics Inc | 350.39% | $1.43 |
Cymabay Therapeutics Inc. | 345.03% | $8.5 |
Aehr Test Systems | 330.11% | $30.28 |
Elf Beauty Inc. | 310.69% | $86.45 |
Astria Therapeutics Inc. | 303.85% | $12.6 |
Enliven Therapeutics Inc | 297.58% | $19.72 |
Clearone Inc. | 297.49% | $2.15 |
Harrow Health Inc. | 265.37% | $22.47 |
Aldeyra Therapeutics Inc. | 257.25% | $9.61 |
Aldeyra Therapeutics Inc. | 257.25% | $9.61 |
Muscle Maker Inc. | 243.8% | $1.15 |
Master Glazier's Karate International Inc. | 231.43% | $5.8 |
Nano Magic Holdings Inc. | 227.5% | $0.655 |
Strategic Environmental & Energy Resources Inc. | 227.27% | $0.18 |
Amylyx Pharmaceuticals Inc | 217.99% | $26.87 |
GlycoMimetics Inc. | 210.34% | $1.8 |
Corvus Pharmaceuticals Inc. | 205.07% | $2.95 |
Heritage Global Inc. | 200% | $3.6 |
Bel Fuse Inc. | 199.36% | $46.52 |
Bel Fuse Inc. | 199.36% | $46.52 |
Cannabis Suisse Corp. | 199% | $0.0598 |
Cidara Therapeutics Inc | 191.68% | $1.34 |
EMagin Corp. | 191.3% | $2.01 |
Dyne Therapeutics Inc. | 186.41% | $13.49 |
BrightRock Gold Corp. | 180.99% | $0.4465 |
Evolv Technologies Holdings Inc. | 165.14% | $5.78 |
Minority Equality Opportunities Acquisition Inc. | 164.08% | $26.54 |
Axsome Therapeutics Inc. | 163.84% | $68.73 |
Fluence Energy Inc. | 163.32% | $22.54 |
BioVie Inc. | 161.9% | $6.6 |
Axcelis Technologies Inc. | 160.43% | $141.05 |
Array Technologies Inc. | 156.72% | $23.67 |
CVRx Inc. | 153.8% | $13.35 |
A1 Group Inc. | 150.7% | $0.0178 |
Cogent Biosciences Inc. | 150.54% | $11.6 |